Protopic Adherence and Efficacy in Korean Eczema Patient

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02126176

Enrollment

Registered

2014-04-29

Start date

2014-05-31

Completion date

2016-03-31

Last updated

2016-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic Dermatitis

Brief summary

The purpose of this study is to determine whether the dosage of 0.1% tacrolimus ointment applied on unit area of eczema influence the efficacy of treatment.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

19 Years to No maximum

Healthy volunteers

Inclusion criteria

* at least 19 years of age with a diagnosis of atopic dermatitis * treated with protopic 0.1% ointment

Exclusion criteria

* treated with other medication or topical agent * skin lesion on the scalp or hand and foot * pregnant women/lactating women

Design outcomes

Primary

Measure	Time frame	Description
clinical assessments of erythema, scaling, and pruritus	2 weeks	EASI score

Countries

South Korea

Outcome results